Verminoside attenuates inflammatory responses in microglial cells and exerts neuroprotective effects in a mouse model of Parkinson’s disease
In summary, VMS prevents dopaminergic neuron degeneration and alleviates behavioral impairments by suppressing NF-κB-mediated neuroinflammation, highlighting its potential as a therapeutic drug for Parkinson's disease.
Authors
- Lili Cai (ORCID: https://orcid.org/0000-0003-3260-2367)
- Guicheng Du
- Chong Wang (ORCID: https://orcid.org/0000-0003-4489-4344)
- Jiawen Wang (ORCID: https://orcid.org/0000-0002-9382-9496)
- Li Yu
Institutions
- Xiamen University (CN)
Publication Details
- Journal
- Neuroreport
- Published
- 2025-10-27
- DOI
- https://doi.org/10.1097/wnr.0000000000002227
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00